[1]
|
Basta, F., Fasola, F., Triantafyllias, K. and Schwarting, A. (2020) Systemic Lupus Erythematosus (SLE) Therapy: The Old and the New. Rheumatology and Therapy, 7, 433-446. https://doi.org/10.1007/s40744-020-00212-9
|
[2]
|
Ameer, M.A., Chaudhry, H., Mushtaq, J., et al. (2022) An Overview of Systemic Lupus Erythematosus (SLE) Pathogenesis, Classification, and Management. Cureus, 14, e30330. https://doi.org/10.7759/cureus.30330
|
[3]
|
Mohamed, A., Chen, Y., Wu, H., et al. (2019) Therapeutic Advances in the Treatment of SLE. International Immunopharmacology, 72, 218-223. https://doi.org/10.1016/j.intimp.2019.03.010
|
[4]
|
Mathian, A., Arnaud, L. and Ruiz-Irastorza, G. (2023) Is It Safe to Withdraw Low-Dose Glucocorticoids in SLE Patients in Remission? Autoimmunity Reviews, Article ID: 103446. https://doi.org/10.1016/j.autrev.2023.103446
|
[5]
|
Park, J.S. and Perl, A. (2023) Endosome Traffic Modulates Pro-Inflammatory Signal Transduction in CD4+ T Cells—Implications for the Pathogenesis of Systemic Lupus Erythe-matosus. International Journal of Molecular Sciences, 24, Article No. 10749. https://doi.org/10.3390/ijms241310749
|
[6]
|
Nakayamada, S. and Tanaka, Y. (2023) Immune Phenotype as a Bi-omarker for Systemic Lupus Erythematosus. Biomolecules, 13, Article No. 960. https://doi.org/10.3390/biom13060960
|
[7]
|
Tuzlak, S., Dejean, A.S., Iannacone, M., et al. (2021) Repositioning TH Cell Polarization from Single Cytokines to Complex Help. Nature Immunology, 22, 1210-1217. https://doi.org/10.1038/s41590-021-01009-w
|
[8]
|
Mohan, C., Zhang, T. and Putterman, C. (2023) Pathogenic Cellular and Molecular Mediators in Lupus Nephritis. Nature Reviews Nephrology, 19, 491-508. https://doi.org/10.1038/s41581-023-00722-z
|
[9]
|
Shan, J., Jin, H. and Xu, Y. (2020) T Cell Metabolism: A New Perspective on Th17/Treg Cell Imbalance in Systemic Lupus Erythematosus. Frontiers in Immunology, 11, Article 1027. https://doi.org/10.3389/fimmu.2020.01027
|
[10]
|
Petrić, M. and Radić, M. (2023) Is Th17-Targeted Therapy Effec-tive in Systemic Lupus Erythematosus? Current Issues in Molecular Biology, 45, 4331-4343. https://doi.org/10.3390/cimb45050275
|
[11]
|
Zhong, W., Feng, L., Tian, W., et al. (2023) SMURF1 Inhibits the Th17 and Th17.1 Polarization and Improves the Treg/Th17 Imbalance in Systemic Lupus Erythematosus through the Ubiquitination of RORγt. Molecular Immunology, 157, 186-194. https://doi.org/10.1016/j.molimm.2023.03.024
|
[12]
|
Jiang, Q., Yang, G., Xiao, F., et al. (2021) Role of Th22 Cells in the Pathogenesis of Autoimmune Diseases. Frontiers in Immunology, 12, Article 688066. https://doi.org/10.3389/fimmu.2021.688066
|
[13]
|
Zhang, Y., Pan, Y., Zhang, P., et al. (2023) AhR Agonist Tapinarof Ameliorates Lupus Autoimmunity by Suppressing Tfh Cell Differentiation via Regulation of the JAK2-STAT3 Signaling Pathway. Immunity, Inflammation and Disease, 11, e903. https://doi.org/10.1002/iid3.903
|
[14]
|
Xipell, M., Lledó, G.M., Egan, A.C., et al. (2023) From Systemic Lupus Erythematosus to Lupus Nephritis: The Evolving Road to Targeted Therapies. Autoimmunity Reviews, 22, Article ID: 103404.
https://doi.org/10.1016/j.autrev.2023.103404
|
[15]
|
Seddon, B. and Yates, A.J. (2018) The Natural History of Naive T Cells from Birth to Maturity. Immunological Reviews, 285, 218-232. https://doi.org/10.1111/imr.12694
|
[16]
|
Park, H., Li, Z., Yang, X.O., et al. (2005) A Distinct Lineage of CD4 T Cells Regulates Tissue Inflammation by Producing Interleukin 17. Nature Immunology, 6, 1133-1141. https://doi.org/10.1038/ni1261
|
[17]
|
Zhou, L., Lopes, J.E., Chong, M.M.W., et al. (2008) TGF-β-Induced Foxp3 Inhibits TH17 Cell Differentiation by Antagonizing RORγt Function. Nature, 453, 236-240. https://doi.org/10.1038/nature06878
|
[18]
|
Korn, T. and Hiltensperger, M. (2021) Role of IL-6 in the Commitment of T Cell Subsets. Cytokine, 146, Article ID: 155654. https://doi.org/10.1016/j.cyto.2021.155654
|
[19]
|
Brockmann, L., Giannou, A.D., Gagliani, N. and Huber, S. (2017) Regulation of TH17 Cells and Associated Cytokines in Wound Heal-ing, Tissue Regeneration, and Carcinogenesis. International Journal of Molecular Sciences, 18, Article No. 1033. https://doi.org/10.3390/ijms18051033
|
[20]
|
Tristão, F.S.M., Rocha, F.A., Carlos, D., et al. (2017) Th17-Inducing Cytokines IL-6 and IL-23 Are Crucial for Granuloma Formation during Experimental Paracoccidioidomycosis. Frontiers in Immunology, 8, Article 949.
https://doi.org/10.3389/fimmu.2017.00949
|
[21]
|
Shen, H. and Chen, Z.W. (2018) The Crucial Roles of Th17-Related Cytokines/Signal Pathways in M. tuberculosis Infection. Cellular & Molecular Immunology, 15, 216-225. https://doi.org/10.1038/cmi.2017.128
|
[22]
|
Bordon, Y. (2014) T Cells: Spotting the Troublemakers. Nature Reviews Immunology, 14, 64-65.
https://doi.org/10.1038/nri3610
|
[23]
|
Ramesh, R., Kozhaya, L., McKevitt, K., et al. (2014) Pro-Inflammatory Hu-man Th17 Cells Selectively Express P-Glycoprotein and Are Refractory to Glucocorticoids. Journal of Experimental Medicine, 211, 89-104.
https://doi.org/10.1084/jem.20130301
|
[24]
|
Acosta-Rodriguez, E., Rivino, L., Geginat, J., et al. (2007) Surface Phenotype and Antigenic Specificity of Human Interleukin 17-Producing T Helper Memory Cells. Nature Immunology, 8, 639-646. https://doi.org/10.1038/ni1467
|
[25]
|
Larosa, M., Zen, M., Gatto, M., et al. (2019) IL-12 and IL-23/Th17 Axis in Systemic Lupus Erythematosus. Experimental Biology and Medicine, 244, 42-51. https://doi.org/10.1177/1535370218824547
|
[26]
|
Celada, L.J., Kropski, J.A., Herazo-Maya, J.D., et al. (2018) PD-1 Up-Regulation on CD4+ T Cells Promotes Pulmonary Fibrosis through STAT3-Mediated IL-17A and TGF-β1 Production. Science Translational Medicine, 10.
https://doi.org/10.1126/scitranslmed.aar8356
|
[27]
|
Singh, K., Rathore, U., Rai, M.K., et al. (2022) Novel Th17 Lymphocyte Populations, Th17.1 and PD1+Th17, Are Increased in Takayasu Arteritis, and Both Th17 and Th17.1 Sub-Populations Associate with Active Disease. Journal of Inflammation Research, 15, 1521-1541. https://doi.org/10.2147/JIR.S355881
|
[28]
|
Benham, H., Norris, P., Goodall, J., et al. (2013) Th17 and Th22 Cells in Psoriatic Arthritis and Psoriasis. Arthritis Research & Therapy, 15, Article No. R136. https://doi.org/10.1186/ar4317
|
[29]
|
Ruiz de Morales, J., Puig, L., Daudén, E., et al. (2020) Critical Role of Inter-leukin (Il)-17 in Inflammatory and Immune Disorders: An Updated Review of the Evidence Focusing in Controversies. Autoimmunity Reviews, 19, Article ID: 102429. https://doi.org/10.1016/j.autrev.2019.102429
|
[30]
|
Taams, L.S. (2020) Interleukin-17 in Rheumatoid Arthritis: Trials and Tribulations. Journal of Experimental Medicine, 217, e20192048. https://doi.org/10.1084/jem.20192048
|
[31]
|
Edavalath, S., Rai, M.K., Gupta, V., et al. (2022) Tacroli-mus Induces Remission in Refractory and Relapsing Lupus Nephritis by Decreasing P-Glycoprotein Expression and Function on Peripheral Blood Lymphocytes. Rheumatology International, 42, 1347-1354. https://doi.org/10.1007/s00296-021-05057-1
|
[32]
|
Arger, N.K., Machiraju, S., Allen, I.E., Woodruff, P.G. and Koth, L.L. (2020) T-Bet Expression in Peripheral Th17.0 Cells Is Associated with Pulmonary Function Changes in Sar-coidosis. Frontiers in Immunology, 11, Article 1129.
https://doi.org/10.3389/fimmu.2020.01129
|
[33]
|
Lepzien, R., Nie, M., Czarnewski, P., et al. (2022) Pulmonary and Blood Dendritic Cells from Sarcoidosis Patients More Potently Induce IFNγ-Producing Th1 Cells Compared with Mon-ocytes. Journal of Leukocyte Biology, 111, 857-866. https://doi.org/10.1002/JLB.5A0321-162R
|
[34]
|
van Lange-laar, J., van der Vuurst de Vries, R.M., Janssen, M., et al. (2018) T Helper 17.1 Cells Associate with Multiple Sclerosis Disease Activity: Perspectives for Early Intervention. Brain, 141, 1334-1349.
https://doi.org/10.1093/brain/awy069
|
[35]
|
Basdeo, S.A., Cluxton, D., Sulaimani, J., et al. (2017) Ex-Th17 (Non-classical Th1) Cells Are Functionally Distinct from Classical Th1 and Th17 Cells and Are Not Constrained by Regulatory T Cells. Journal of Immunology, 198, 2249-2259. https://doi.org/10.4049/jimmunol.1600737
|
[36]
|
Rother, N. and van der Vlag, J. (2015) Disturbed T Cell Signaling and Altered Th17 and Regulatory T Cell Subsets in the Pathogenesis of Systemic Lupus Erythematosus. Frontiers in Immunology, 6, Article 610.
https://doi.org/10.3389/fimmu.2015.00610
|
[37]
|
Hsu, H.-C., Yang, P., Wang, J., et al. (2008) Interleukin 17-Producing T Helper Cells and Interleukin 17 Orchestrate Autoreactive Germinal Center Development in Autoimmune BXD2 Mice. Nature Immunology, 9, 166-175.
https://doi.org/10.1038/ni1552
|
[38]
|
Wong, M., La Cava, A., Singh, R.P. and Hahn, B.H. (2010) Blockade of Pro-grammed Death-1 in Young (New Zealand Black × New Zealand White) F1 Mice Promotes the Activity of Suppressive CD8+ T Cells That Protect from Lupus-Like Disease. Journal of Immunology, 185, 6563-6571. https://doi.org/10.4049/jimmunol.0903401
|
[39]
|
Koga, T., Ichinose, K., Kawakami, A. and Tsokos, G.C. (2019) The Role of IL-17 in Systemic Lupus Erythematosus and Its Potential as a Therapeutic Target. Expert Review of Clinical Immunology, 15, 629-637.
https://doi.org/10.1080/1744666X.2019.1593141
|
[40]
|
Zhong, W., Jiang, Y., Ma, H., et al. (2017) Elevated Levels of CCR6+ T Helper 22 Cells Correlate with Skin and Renal Impairment in Systemic Lupus Erythematosus. Scientific Re-ports, 7, Article No. 12962.
https://doi.org/10.1038/s41598-017-13344-w
|
[41]
|
Zickert, A., Amoudruz, P., Sundström, Y., et al. (2015) IL-17 and IL-23 in Lupus Nephritis—Association to Histopathology and Response to Treatment. BMC Immunology, 16, Arti-cle No. 7. https://doi.org/10.1186/s12865-015-0070-7
|
[42]
|
Shenoy, S., Chaurasia, S., Edavalath, S., et al. (2018) Effect of Induction Therapy on Circulating T-Helper 17 and T-Regulatory Cells in Active Proliferative Lupus Nephritis. International Journal of Rheumatic Diseases, 21, 1040-1048.
https://doi.org/10.1111/1756-185X.13272
|
[43]
|
Jakiela, B., Kosałka, J., Plutecka, H., et al. (2018) Facilitated Ex-pansion of Th17 Cells in Lupus Nephritis Patients. Clinical and Experimental Immunology, 194, 283-294. https://doi.org/10.1111/cei.13196
|
[44]
|
Zhong, W., Jiang, Z., Wu, J., et al. (2018) CCR6+ Th Cell Distribution Dif-ferentiates Systemic Lupus Erythematosus Patients Based on Anti-dsDNA Antibody Status. PeerJ, 6, e4294. https://doi.org/10.7717/peerj.4294
|
[45]
|
Yang, J., Chu, Y., Yang, X., et al. (2009) Th17 and Natural Treg Cell Pop-ulation Dynamics in Systemic Lupus Erythematosus. Arthritis & Rheumatology, 60, 1472-1483. https://doi.org/10.1002/art.24499
|
[46]
|
Wen, Z., Xu, L., Xu, W. and Xiong, S. (2014) Detection of Dynamic Fre-quencies of Th17 Cells and Their Associations with Clinical Parameters in Patients with Systemic Lupus Erythematosus Receiving Standard Therapy. Clinical Rheumatology, 33, 1451-1458. https://doi.org/10.1007/s10067-014-2656-5
|
[47]
|
El-Behi, M., Ciric, B., Dai, H., et al. (2011) The Encephalitogen-icity of TH17 Cells Is Dependent on IL-1- and IL-23-Induced Production of the Cytokine GM-CSF. Nature Immunology, 12, 568-575. https://doi.org/10.1038/ni.2031
|
[48]
|
Du, J., Li, Z., Shi, J. and Bi, L. (2014) Associations between Serum Interleukin-23 Levels and Clinical Characteristics in Patients with Systemic Lupus Erythematosus. Journal of In-ternational Medical Research, 42, 1123-1130.
https://doi.org/10.1177/0300060513509130
|